ArticleInternational journal of molecular sciences2022

Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.

Soyoung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.